thisdrug what a medicine's name tells you

WHO naming stem · prefix · 33 listed names

nitro-/nitr-/nit-/ni-/-ni-

This page was written with AI.

NO2 - derivatives

WHO's definition, quoted as written in the 2024 stem book

6 of 33 names appear in these lists: 6 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 11 have national brands in at least one EU/EEA country.

Names only. This page is about nitro-/nitr-/nit-/ni-/-ni- as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as nitro-/nitr-/nit-/ni-/-ni-. It has 5 spellings or places: nitro at the start of the name (nitro…); nitr at the start of the name (nitr…); nit at the start of the name (nit…); ni at the start of the name (ni…); ni inside the name, with letters before and after it (…ni…).

Of the 33 names WHO lists under it, 10 carry nitro at the start of the name, 8 carry nitr at the start of the name, 1 carry nit at the start of the name, 13 carry ni at the start of the name, 1 carry ni inside the name, with letters before and after it.

All 33 names WHO lists under nitro-/nitr-/nit-/ni-/-ni-

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 6 of 33 names appear in these lists: 6 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 11 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. nibroxane
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. nicardipine
    US brands: CARDENE, CARDENE SR (discontinued in FDA listings)
    EU (central) brands: none found
  3. niclofolan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. niclosamide
    US brands: NICLOCIDE (discontinued in FDA listings)
    EU (central) brands: none found
  5. nidroxyzone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. nifedipine
    US brands: PROCARDIA XL, ADALAT (discontinued in FDA listings), ADALAT CC (discontinued in FDA listings), AFEDITAB CR (discontinued in FDA listings), PROCARDIA (discontinued in FDA listings)
    EU (central) brands: none found
  7. nifenalol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. nihydrazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. niludipine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. nimesulide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. nimorazole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. niridazole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. nisoldipine
    US brands: SULAR
    EU (central) brands: none found
  14. nitarsone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. nitracrine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. nitrafudam
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. nitramisole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. nitraquazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. nitrazepam
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. nitrefazole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. nitrendipine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. nitricholine perchlorate
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. nitroclofene
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. nitrocycline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. nitrodan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. nitrofural
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  27. nitrofurantoin
    US brands: FURADANTIN, FURALAN (discontinued in FDA listings), IVADANTIN (discontinued in FDA listings)
    in combination: MACROBID with macrocrystalline; NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) with macrocrystalline; MACRODANTIN (discontinued in FDA listings) with macrocrystalline
    EU (central) brands: none found
  28. nitromifene
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. nitroscanate
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  30. nitrosulfathiazole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. nitroxinil
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. nitroxoline
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  33. ranitidine
    US brands: ZANTAC (discontinued in FDA listings), ZANTAC 150 (discontinued in FDA listings), ZANTAC 25 (discontinued in FDA listings), ZANTAC 300 (discontinued in FDA listings), ZANTAC 75 (discontinued in FDA listings), ZANTAC IN PLASTIC CONTAINER (discontinued in FDA listings)
    EU (central) brands: none found

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Decode another name

Decoded

nitrodan

Listed INNCarries 2 WHO stems, most specific first: nitro-/nitr-/nit-/ni-/-ni- …

  • nitro-/nitr-/nit-/ni-/-ni-start of the nameWHO lists it hereWHO definition: NO2 - derivatives
  • -danend of the nameWHO stem book: WHO lists this name under -dan as not following the stem’s meaning.

“nitrodan” is an INN that WHO lists under nitro-/nitr-/nit-/ni-/-ni- in the 2024 stem book. WHO’s 2024 stem book lists “nitrodan” under -dan as a name in which the stem’s letters are used, but not in accordance with its definition (group b).

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of nitro-/nitr-/nit-/ni-/-ni- (Part II B) and the 33 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy